N
News Analysis
dailypolitical.com

www.dailypolitical.com ·

Positive

tejara capital ltd grows position in cardiol therapeutics inc crdl

GENERAL_HEALTHTAX_DISEASE_DISEASEWB_1406_DISEASESUNGP_HEALTHCARE

All NewsRead the full story on dailypolitical.com

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

AI insight

AI-generated

The news describes institutional investment activity in Cardiol Therapeutics, a biotech firm developing cardiovascular treatments. No direct commercial mechanism (e.g., drug approval, trial results, revenue change) is reported. The impact is limited to equity positioning and does not affect product prices, supply chains, or margins. Sector relevance is weak; included only because the company is a biotech developer.

Signals our AI researcher identified

Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.

  • Tejara Capital Ltd increased its stake in Cardiol Therapeutics by 95.1% in Q4, buying 2.5M shares.
  • Cardiol Therapeutics has a market cap of $153.19M and stock price of $1.37 as of May 15, 2026.
  • Other institutional investors like Bank of America and Citadel also increased positions in Q3.

About the publisher

dailypolitical.com is one of the en-language news outlets that News Analysis aggregates. Coverage from this source appears in our global feed alongside the publisher's own reporting.

Topic context

dailypolitical.com files this story under "general health" in the GDELT knowledge graph. News Analysis surfaces coverage based on the same open classification taxonomy.

tejara capital ltd grows position in cardiol therapeutics inc crdl | dailypolitical.com — News Analysis